Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Madan

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
BMC Health Services Research|November 19, 2023
Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and UgandaLaura Rosu, Jason Madan, Gay Bronson, et al.
Pharmaceutical Statistics|January 12, 2018
Approaches to sample size calculation for clinical trials in rare diseasesFrank Miller, Sarah Zohar, Nigel Stallard, et al.
BJR Artificial Intelligence|May 1, 2026
Translating potential improvement in the precision and accuracy of lung nodule measurements on computed tomography scans by software derived from artificial intelligence into impact on clinical practice-a simulation studyMubarak Patel, Peter Auguste, Jason Madan, et al.
Orphanet Journal of Rare Diseases|March 4, 2017
Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.govSiew Wan Hee, Adrian Willis, Catrin Tudur Smith, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and WalesRachid Rafia, Alan Brennan, Jason Madan, et al.
BMJ Open|June 9, 2018
Standard wound management versus negative-pressure wound therapy in the treatment of adult patients having surgical incisions for major trauma to the lower limb-a two-arm parallel group superiority randomised controlled trial: protocol for Wound Healing in Surgery for Trauma (WHIST)Juul Achten, Karan Vadher, Julie Bruce, et al.
Health Technology Assessment (Winchester, England)|June 25, 2021
Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluationChris Stinton, Mary Jordan, Hannah Fraser, et al.
BMJ Open|January 20, 2016
Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysisSian Taylor-Phillips, Karoline Freeman, Julia Geppert, et al.
Thorax|November 3, 2019
Delivery of long-term-injectable agents for TB by lay carers: pragmatic randomised trialDanielle B Cohen, Kuzani Mbendera, Hendramoorthy Maheswaran, et al.
JMIR Medical Informatics|November 1, 2018
Benefits and Costs of Digital Consulting in Clinics Serving Young People With Long-Term Conditions: Mixed-Methods ApproachSung Wook Kim, Jason Madan, Melina Dritsaki, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
BMC Health Services Research|November 19, 2023
Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and UgandaLaura Rosu, Jason Madan, Gay Bronson, et al.
Pharmaceutical Statistics|January 12, 2018
Approaches to sample size calculation for clinical trials in rare diseasesFrank Miller, Sarah Zohar, Nigel Stallard, et al.
BJR Artificial Intelligence|May 1, 2026
Translating potential improvement in the precision and accuracy of lung nodule measurements on computed tomography scans by software derived from artificial intelligence into impact on clinical practice-a simulation studyMubarak Patel, Peter Auguste, Jason Madan, et al.
Orphanet Journal of Rare Diseases|March 4, 2017
Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.govSiew Wan Hee, Adrian Willis, Catrin Tudur Smith, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and WalesRachid Rafia, Alan Brennan, Jason Madan, et al.
BMJ Open|June 9, 2018
Standard wound management versus negative-pressure wound therapy in the treatment of adult patients having surgical incisions for major trauma to the lower limb-a two-arm parallel group superiority randomised controlled trial: protocol for Wound Healing in Surgery for Trauma (WHIST)Juul Achten, Karan Vadher, Julie Bruce, et al.
Health Technology Assessment (Winchester, England)|June 25, 2021
Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluationChris Stinton, Mary Jordan, Hannah Fraser, et al.
BMJ Open|January 20, 2016
Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysisSian Taylor-Phillips, Karoline Freeman, Julia Geppert, et al.
Thorax|November 3, 2019
Delivery of long-term-injectable agents for TB by lay carers: pragmatic randomised trialDanielle B Cohen, Kuzani Mbendera, Hendramoorthy Maheswaran, et al.
JMIR Medical Informatics|November 1, 2018
Benefits and Costs of Digital Consulting in Clinics Serving Young People With Long-Term Conditions: Mixed-Methods ApproachSung Wook Kim, Jason Madan, Melina Dritsaki, et al.
Pageof 12